Replies to post #229929 on Elite Pharmaceuticals Inc (ELTP)

[no2koolaid]

We get your point. Not sure how many angles it can take and still arrive at the same issue...Elite should come out with a PR. Yet, I would offer a contrarian view...How two weeks ago Brent Saunders, CEO of Allergan, went on a business news show to comment on the Tobira acquisition and add his commitment to work to increasing the AGN share price. As an investor in the company, I was most interested in what he said. The p/s at the time of his comments was around 240. It is 233 today, having dropped to 229 yesterday. So much for the impact of a fluff PR! And, by the way, I think Saunders is a first rate CEO and has some great ideas on pharma pricing. But that is for another time...